nicardipine has been researched along with Sclerosis, Systemic in 5 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifteen patients with Raynaud's phenomenon [systemic lupus erythematosus (6), progressive systemic sclerosis (8) and rheumatoid arthritis (1)] and 12 patients with Raynaud's disease participated in a parallel, 4-week/arm, double blind, crossover study of nicardipine, an experimental calcium channel blocker." | 5.06 | Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker. ( Dorsey, JK; Furst, DE; Kohler, J; Mellinger, S; Rupp, PA, 1987) |
| " We evaluated the pharmacodynamic effect of the calcium channel blocker nicardipine on left ventricular function assessed by radionuclide ventriculography in 20 patients with systemic sclerosis." | 1.28 | Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis. ( Amor, B; Devaux, JY; Guérin, F; Kahan, A; Menkès, CJ; Strauch, G; Venot, A; Weber, S, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meune, C | 1 |
| Allanore, Y | 1 |
| Devaux, JY | 3 |
| Dessault, O | 1 |
| Duboc, D | 1 |
| Weber, S | 3 |
| Kahan, A | 3 |
| Amor, B | 2 |
| Menkès, CJ | 2 |
| Guérin, F | 2 |
| Venot, A | 2 |
| Strauch, G | 1 |
| McCarthy, G | 1 |
| Kenny, D | 1 |
| Degeorges, M | 1 |
| Roucayrol, JC | 1 |
| Rupp, PA | 1 |
| Mellinger, S | 1 |
| Kohler, J | 1 |
| Dorsey, JK | 1 |
| Furst, DE | 1 |
1 trial available for nicardipine and Sclerosis, Systemic
| Article | Year |
|---|---|
Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Hemod | 1987 |
4 other studies available for nicardipine and Sclerosis, Systemic
| Article | Year |
|---|---|
High prevalence of right ventricular systolic dysfunction in early systemic sclerosis.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Nicardipine; Radionuclide | 2004 |
Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis.
Topics: Adult; Aged; Female; Heart; Heart Ventricles; Humans; Male; Middle Aged; Nicardipine; Radionuclide V | 1990 |
Nicardipine in systemic sclerosis.
Topics: Coronary Circulation; Coronary Disease; Humans; Nicardipine; Scleroderma, Systemic | 1989 |
Nicardipine improves myocardial perfusion in systemic sclerosis.
Topics: Adult; Coronary Circulation; Female; Heart; Humans; Male; Middle Aged; Nicardipine; Scleroderma, Sys | 1988 |